These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23677428)

  • 1. Paradoxical increase in uric acid level with allopurinol use in pyrazinamide-induced hyperuricaemia.
    Gerdan V; Akkoc N; Ucan ES; Bulac Kir S
    Singapore Med J; 2013 Jun; 54(6):e125-6. PubMed ID: 23677428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of efficacy and safety of febuxostat and allopurinol in pyrazinamide-induced hyperuricemic tubercular patients.
    Pichholiya M; Yadav AK; Luhadia SK; Tahashildar J; Aseri ML
    Indian J Pharmacol; 2016; 48(5):522-525. PubMed ID: 27721537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Hyperuricemia Overlooked when Treating Pediatric Tuberculosis Patients with Pyrazinamide?
    Şişmanlar T; Aslan AT; Budakoğlu I
    J Trop Pediatr; 2015 Oct; 61(5):351-6. PubMed ID: 26136257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazinamide induced hyperuricemia in patients taking anti-tuberculous therapy.
    Solangi GA; Zuberi BF; Shaikh S; Shaikh WM
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):136-8. PubMed ID: 15228843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allopurinol hypersensitivity. A possible cause of hepatitis and mucocutaneous eruptions in a patient undergoing antitubercular treatment].
    Urban T; Maquarre E; Housset C; Chouaid C; Devin E; Lebeau B
    Rev Mal Respir; 1995; 12(3):314-6. PubMed ID: 7638430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between allopurinol and pyrazinamide.
    Lacroix C; Guyonnaud C; Chaou M; Duwoos H; Lafont O
    Eur Respir J; 1988 Oct; 1(9):807-11. PubMed ID: 3229478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperuricemia and arthralgia during pyrazinamide treatment].
    Inoue T; Ikeda N; Kurasawa T; Sato A; Nakatani K; Ikeda T; Yoshimatsu H
    Nihon Kokyuki Gakkai Zasshi; 1999 Feb; 37(2):115-8. PubMed ID: 10214039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazinamide induced hyperuricaemia presenting as severe bilateral leg cramps.
    Gupta S; Gupta V; Kapoor B; Kapoor V
    J Indian Med Assoc; 2007 Jun; 105(6):341-2. PubMed ID: 18232182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological survey of hyperuricemia as an adverse reaction to antituberculous therapy with pyrazinamide.
    Taki H; Ogawa K; Murakami T; Nikai T
    Kekkaku; 2008 Jul; 83(7):497-501. PubMed ID: 18709966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyrazinamide, hyperuricemia and gouty arthritis].
    Auvergne B; Lioté R; Roucoulès J; Kuntz D
    Rev Rhum Mal Osteoartic; 1988 Oct; 55(10):797. PubMed ID: 3264079
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double blind controlled comparison of aspirin, allopurinol and placebo in the management of arthralgia during pyrazinamide administration.
    Horsfall PA; Plummer J; Allan WG; Girling DJ; Nunn AJ; Fox W
    Tubercle; 1979 Mar; 60(1):13-24. PubMed ID: 377739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F
    Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
    Whelton A; MacDonald PA; Chefo S; Gunawardhana L
    Postgrad Med; 2013 Jan; 125(1):106-14. PubMed ID: 23391676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the use of allopurinol to reduce plasma uric acid concentrations in the Red-tailed Hawk (Buteo jamaicensis) hyperuricaemic model.
    Poffers J; Lumeij JT; Timmermans-Sprang EP; Redig PT
    Avian Pathol; 2002 Dec; 31(6):567-72. PubMed ID: 12593739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is pyrazinamide really the third drug of choice in the treatment of tuberculosis?
    Koumbaniou C; Nicopoulos C; Vassiliou M; Manda-Stachouli C; Sakellariou K; Demou GS; Constantopoulos SH
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):675-8. PubMed ID: 9712283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia and gout. Classification, complications and management.
    Boss GR; Seegmiller JE
    N Engl J Med; 1979 Jun; 300(26):1459-68. PubMed ID: 221806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.